Smallpox News and Research

RSS
Smallpox is a highly contagious disease caused by the variola virus, a member of the Orthopox virus family. It is one of the most devastating diseases known to humanity, with a mortality rate as high as 30%. In 1967, the World Health Organization embarked upon an intensified vaccination campaign to eliminate smallpox, which culminated in the successful eradication of the disease globally by 1980.

By the mid-1980s, there were only two known repositories of variola virus: the Institute of Virus Preparations in Russia, and the US CDC. The events in the US in September and October 2001 highlighted the risk that the variola virus might be used as an agent of bioterrorism. Governments around the world are taking precautionary measures to be ready to deal with a potential smallpox outbreak.
First large field trial shows VSV-ZEBOV is effective against Ebola

First large field trial shows VSV-ZEBOV is effective against Ebola

Tests show VSV-ZEBOV vaccine safe and effective against Ebola

Tests show VSV-ZEBOV vaccine safe and effective against Ebola

Guinea Phase III trial shows VSV-EBOV vaccine highly effective against Ebola

Guinea Phase III trial shows VSV-EBOV vaccine highly effective against Ebola

Ebola vaccine study begins in Dakar, Senegal

Ebola vaccine study begins in Dakar, Senegal

Vaccines - a needle-free future? An interview with Thomas Johnston and Dr. Kees Leenhouts, Mucosis

Vaccines - a needle-free future? An interview with Thomas Johnston and Dr. Kees Leenhouts, Mucosis

Sheffield scientists to showcase novel medical discoveries during International Clinical Trials Day

Sheffield scientists to showcase novel medical discoveries during International Clinical Trials Day

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

Guinean Government initiates first efficacy trial of Ebola vaccine in Basse-Guinée

Guinean Government initiates first efficacy trial of Ebola vaccine in Basse-Guinée

Phase III trial to test VSV-EBOV vaccine for preventing Ebola to be launched in Guinea

Phase III trial to test VSV-EBOV vaccine for preventing Ebola to be launched in Guinea

Chimerix, ContraVir collaborate to develop and commercialize antiviral drug candidate CMX157

Chimerix, ContraVir collaborate to develop and commercialize antiviral drug candidate CMX157

New hybrid vehicle to improve delivery of DNA vaccines is under development

New hybrid vehicle to improve delivery of DNA vaccines is under development

Dr. D. A. Henderson named recipient of Prince Mahidol Award in Public Health

Dr. D. A. Henderson named recipient of Prince Mahidol Award in Public Health

Gates Foundation awards US$156 million to support PATH Malaria Vaccine Initiative

Gates Foundation awards US$156 million to support PATH Malaria Vaccine Initiative

Viewpoints: 'Blunders' on Ebola; McConnell's strange logic on Obamacare; temporary victory for Texas women

Viewpoints: 'Blunders' on Ebola; McConnell's strange logic on Obamacare; temporary victory for Texas women

SLU researchers work to prevent several serious infectious diseases

SLU researchers work to prevent several serious infectious diseases

Viewpoints: Medicare's future finances; 'promising deal' on VA; Texas 'war on abortion'

Viewpoints: Medicare's future finances; 'promising deal' on VA; Texas 'war on abortion'

WIRB-Copernicus Group acquires Alliance Biosciences

WIRB-Copernicus Group acquires Alliance Biosciences

Viewpoints: 'Entitlement meltdown;' improving Medicare Advantage; 'sloppy work habits' at CDC

Viewpoints: 'Entitlement meltdown;' improving Medicare Advantage; 'sloppy work habits' at CDC

Viewpoints: Problems in training docs; impact of HHS' territory decision; what Halbig decision might mean

Viewpoints: Problems in training docs; impact of HHS' territory decision; what Halbig decision might mean

Viruses designed to kill cancer cells could boost effectiveness of chemotherapy to arms, legs

Viruses designed to kill cancer cells could boost effectiveness of chemotherapy to arms, legs